An Amylyx Pharmaceuticals drug developed to slow the progression of amyotrophic lateral sclerosis is now approved, making it just the third FDA-approved treatment for the disease. Amylyx will market its new product under the name "Relyvrio."
The world of medical coding has developed dramatically in the past 20 years, echoing an increasingly complex technology landscape of telemedicine, remote patient monitoring, and machine learning. Join us as we will explore how medical coding has evolved and the skills that will be necessary to prepare the next generation of medical coders.
We know that healthcare is big business, but even more than that, it is the final common pathway to all social determinants. I firmly believe that we can still establish an exemplary model of population health — a system that promotes inclusion of all factors associated with a patient's health in order to provide as much comprehensive care as possible.
By Stephanie Baum Friday, September 30, 2022 7:30 AM
Eight companies focused on improving the employee benefits space took part in the Pitch Perfect contest at INVEST Digital Health this week. Here's a look at who won and why.
By Katie Adams Thursday, September 29, 2022 7:26 PM
There are a few key priorities providers and digital health companies should consider in their efforts to better reach patients — including scaling up their commitment to value-based care and working to engage patients beyond their episodic care needs — according to a recent healthcare innovation panel.
By Frank Vinluan Thursday, September 29, 2022 7:16 PM
An Amylyx Pharmaceuticals drug developed to slow the progression of amyotrophic lateral sclerosis is now approved, making it just the third FDA-approved treatment for the disease. Amylyx will market its new product under the name "Relyvrio."
By Marissa Plescia Thursday, September 29, 2022 7:01 PM
Employers are having a difficult time navigating all the point solutions in healthcare. But it's not necessarily a bad thing, as its generating more competition and forcing companies to get creative. Several experts discussed the topic at MedCity's Invest Digital Health conference.
By Stephanie Tilenius Thursday, September 29, 2022 5:28 PM
Of all systematic changes to healthcare, these four adjustments would be easy enough to roll out quickly and would have a massive impact on the country's health outcomes
By David Lareau Thursday, September 29, 2022 5:18 PM
While EHRs are often viewed as essential clinical tools, most were originally designed to facilitate billing operations. By incorporating clinically responsive workflows that readily present the right information to clinicians at the point of care, EHRs can finally fulfill their destiny – to drive better patient care.
By Andrea Bastek Thursday, September 29, 2022 4:46 PM
When patients can travel to a pharmacy or doctor's office in their own neighborhood, they can reach the site on foot or using public transit. They also have to take less time off work and request childcare less often.
By Julian Flannery Thursday, September 29, 2022 12:03 PM
Virtual specialty care networks may provide the sort of longitudinal healthcare relationship we haven't seen since the era of house calls and doctors' bags—benefiting patients and physicians alike.
By Frank Vinluan Thursday, September 29, 2022 11:59 AM
Novo Nordisk is acquiring global rights to a Ventus Therapeutics drug candidate with potential applications in cardiometabolic disorders such as NASH and chronic kidney disease. The small molecule blocks a protein that has become an attractive target for big pharmaceutical companies, such as Roche and Novartis.
Today, the pharmaceutical industry is undergoing a rapid and dynamic transformation. Successful contract management plays an instrumental role in navigating this landscape.
No comments